BDBM667108 1-(4-(7-(5-chloro-2-fluorophenyl)- 2,3-dihydro-1H-pyrido[3,4- b][1,4]oxazin-1-yl)pyridin-2-yl)-3- (2-(4-methylpiperazin-1- yl)ethyl)urea::US20240116947, Example 55

SMILES CN1CCN(CCNC(=O)Nc2cc(ccn2)N2CCOc3cnc(cc23)-c2cc(Cl)ccc2F)CC1

InChI Key InChIKey=SATBNJLVQXFABB-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 667108   

TargetTGF-beta receptor type-1(Human)
Chiesi Farmaceutici

US Patent
LigandPNGBDBM667108(US20240116947, Example 55 | 1-(4-(7-(5-chloro-2-fl...)
Affinity DataIC50: 1nMAssay Description:The enzymatic activity of compounds of the present invention was monitored measuring the formation of ADP using the ADP-GLO Kinases assay. Following ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent